| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7927 |
| Human Intestinal Absorption | HIA+ | 0.9892 |
| Caco-2 Permeability | Caco2- | 0.6157 |
| P-glycoprotein Substrate | Non-substrate | 0.6453 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5185 |
| Non-inhibitor | 0.7509 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6957 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4653 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6516 |
| CYP450 2D6 Substrate | Non-substrate | 0.8178 |
| CYP450 3A4 Substrate | Substrate | 0.5243 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5153 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5078 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8897 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5140 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6157 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5638 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6503 |
| Non-inhibitor | 0.5704 |
| AMES Toxicity | Non AMES toxic | 0.6181 |
| Carcinogens | Non-carcinogens | 0.8573 |
| Fish Toxicity | High FHMT | 0.5595 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7002 |
| Honey Bee Toxicity | Low HBT | 0.7440 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7910 |
| Carcinogenicity (Three-class) | Non-required | 0.5205 |